PERVILLEINE-A-N-OXIDE;3-ALPHA-(3,4,5-TRIMETHOXYBENZOYLOXY)-6-BETA-(E)-(3,4,5-TRIMETHOXYCINNAMOYLOXY)-7-BETA-HYDROXYTROPANE-N-OXIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Cbly6zwf93D |
|---|---|
| InChI | InChI=1S/C30H37NO12/c1-31(35)19-14-18(42-30(34)17-12-23(38-4)29(41-7)24(13-17)39-5)15-20(31)27(26(19)33)43-25(32)9-8-16-10-21(36-2)28(40-6)22(11-16)37-3/h8-13,18-20,26-27,33H,14-15H2,1-7H3/b9-8+/t18-,19+,20-,26+,27-,31+/m0/s1 |
| InChIKey | IIQSEOKVYKKMBG-LYGRJKCMSA-N |
| Mol Weight | 603.6 g/mol |
| Molecular Formula | C30H37NO12 |
| Exact Mass | 603.231576 g/mol |
| Enantiomer InChIKey | IIQSEOKVYKKMBG-ZAPWXEEYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Benzamide, N-[1-(2-fluorophenyl)-2,5-dioxo-4-(trifluoromethyl)-4-imidazolidinyl]-3,4,5-trimethoxy-
2'-O-ALLYL-GUANOSINE
TORTUOSINE
2-Methyl-7-phenyl-1-(3,4,5-trimethoxyphenyl)-6-purinone
DLLBJSLIKOKFHE-GTBBIVDNSA-N
EPIACALYPHIN;(+)-(5R,6R)-5-CYANO-5-BETA-D-GLUCOPYRANOSYLOXY-6-HYDROXY-4-METHOXY-1-METHYL-2-(5,6-DIHYDRO)-PYRIDONE
N-(2-methoxy-5-nitrophenyl)-3-methyl-2-(4-methylphenyl)-4-quinolinecarboxamide
FUCATOSIDE_B;1-O-3,4-(DIHYDROXYPHENYL)-ETHYL-BETA-D-APIOFURANOSYL-(1->2)-BETA-D-XYLOPYRANOSYL-(1->3)-4-O-CAFFEOYL-BETA-D-GLUCOPYRANOSIDE
3-(2-Benzo[1,3]dioxol-5-yl-2,3-dihydro-benzo[b][1,4]thiazepin-4-yl)-4-hydroxy-6-methyl-pyran-2-one
3',5-diacetoxy-2',4,4',6-tetramethxoy-6'-(prop-1-enyl)biphenyl-2-carbaldehyde
| Title | Journal or Book | Year |
|---|---|---|
| Modulation of the Multidrug-Resistance Phenotype by New Tropane Alkaloid Aromatic Esters from Erythroxylum pervillei | Journal of Natural Products | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.